SG11201805474PA - Cyclic amine derivative and medical use thereof - Google Patents
Cyclic amine derivative and medical use thereofInfo
- Publication number
- SG11201805474PA SG11201805474PA SG11201805474PA SG11201805474PA SG11201805474PA SG 11201805474P A SG11201805474P A SG 11201805474PA SG 11201805474P A SG11201805474P A SG 11201805474PA SG 11201805474P A SG11201805474P A SG 11201805474PA SG 11201805474P A SG11201805474P A SG 11201805474PA
- Authority
- SG
- Singapore
- Prior art keywords
- medical use
- amine derivative
- cyclic amine
- cyclic
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/38—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Portable Nailing Machines And Staplers (AREA)
- Toys (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016015512 | 2016-01-29 | ||
| JP2016212629 | 2016-10-31 | ||
| PCT/JP2017/002924 WO2017131156A1 (en) | 2016-01-29 | 2017-01-27 | Cyclic amine derivative and pharmaceutical use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201805474PA true SG11201805474PA (en) | 2018-07-30 |
Family
ID=59398579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201805474PA SG11201805474PA (en) | 2016-01-29 | 2017-01-27 | Cyclic amine derivative and medical use thereof |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10364222B2 (en) |
| EP (1) | EP3409660B1 (en) |
| JP (1) | JP6807054B2 (en) |
| KR (1) | KR20180100573A (en) |
| CN (1) | CN108473426B (en) |
| AU (1) | AU2017210685B2 (en) |
| BR (1) | BR112018015125A2 (en) |
| CA (1) | CA3009971C (en) |
| DK (1) | DK3409660T3 (en) |
| ES (1) | ES2822606T3 (en) |
| HU (1) | HUE050744T2 (en) |
| IL (1) | IL260230B (en) |
| MX (1) | MX2018008454A (en) |
| MY (1) | MY195416A (en) |
| PH (1) | PH12018501434A1 (en) |
| PL (1) | PL3409660T3 (en) |
| PT (1) | PT3409660T (en) |
| RU (1) | RU2696862C1 (en) |
| SG (1) | SG11201805474PA (en) |
| TR (1) | TR201912580U5 (en) |
| TW (1) | TWI691486B (en) |
| WO (1) | WO2017131156A1 (en) |
| ZA (1) | ZA201804325B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2019022234A1 (en) * | 2017-07-27 | 2020-05-28 | 東レ株式会社 | Therapeutic agent or preventive agent for inflammatory bowel disease |
| EP3659602A4 (en) | 2017-07-27 | 2021-06-09 | Toray Industries, Inc. | Therapeutic agent or prophylactic agent for alopecia areata |
| WO2019022223A1 (en) * | 2017-07-28 | 2019-01-31 | 東レ株式会社 | Cyclic amine derivative and use thereof for medical purposes |
| JPWO2019044940A1 (en) * | 2017-08-31 | 2020-08-13 | 東レ株式会社 | Cyclic amine derivative and its pharmaceutical use |
| US20200392107A1 (en) | 2018-01-31 | 2020-12-17 | Toray Industries, Inc. | Cyclic amine derivative and medical use thereof |
| US11242350B2 (en) | 2018-03-12 | 2022-02-08 | Escalier Biosciences B.V. | Spirocyclic ROR-gamma modulators |
| WO2019177996A1 (en) * | 2018-03-12 | 2019-09-19 | Escalier Biosciences B.V. | Bicyclic ror-gamma modulators |
| CN111548303A (en) * | 2020-06-28 | 2020-08-18 | 山东美泰医药有限公司 | Levobupivacaine hydrochloride impurity and preparation and analysis method thereof |
| CN113252831B (en) * | 2021-05-20 | 2022-08-26 | 京博农化科技有限公司 | Ultra-high performance liquid chromatography analysis method for N-chloroformyl-N- [4- (trifluoromethoxy) phenyl ] methyl carbamate |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ563522A (en) * | 2005-04-22 | 2010-01-29 | Daiichi Sankyo Co Ltd | Heterocyclic compound with immunosuppressive activity |
| GB0510139D0 (en) | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B1 |
| CA2706679A1 (en) * | 2007-12-12 | 2009-06-18 | Astrazeneca Ab | Novel compounds 010 |
| KR20110028661A (en) | 2008-07-15 | 2011-03-21 | 노파르티스 아게 | Heteroaryl derivatives as dgat1 inhibitors |
| WO2010096371A2 (en) | 2009-02-18 | 2010-08-26 | Boehringer Ingelheim International Gmbh | Heterocyclic compounds which modulate the cb2 receptor |
| WO2012027965A1 (en) * | 2010-09-01 | 2012-03-08 | Glaxo Group Limited | Novel compounds |
| CA2816753A1 (en) | 2010-11-08 | 2012-05-18 | Lycera Corporation | N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory activity and the treatment of diseases |
| US8604069B2 (en) | 2011-04-28 | 2013-12-10 | Japan Tobacco Inc. | Amide compound and medicinal use thereof |
| US9586928B2 (en) | 2011-05-16 | 2017-03-07 | The Scripps Research Institute | Modulators of the nuclear hormone receptor ROR |
| WO2013018695A1 (en) | 2011-07-29 | 2013-02-07 | 武田薬品工業株式会社 | Heterocyclic compound |
| GB201207406D0 (en) * | 2012-04-27 | 2012-06-13 | Glaxo Group Ltd | Novel compounds |
| UY34832A (en) | 2012-05-31 | 2013-12-31 | Phenex Pharmaceuticals Ag | TIAZOLS REPLACED BY CARBOXAMIDE OR SULFONAMIDE AND RELATED DERIVATIVES AS MODULATORS FOR THE NURLEAR RECEPTOR HUÉRFANO RORy (lambda) |
| CA2906035A1 (en) * | 2013-03-14 | 2014-09-25 | Celtaxsys, Inc. | Inhibitors of leukotriene a4 hydrolase |
| EP3092215B1 (en) * | 2014-01-06 | 2018-10-17 | Bristol-Myers Squibb Company | Cyclohexyl sulfone ror gamma modulators |
| JP6574444B2 (en) * | 2014-01-06 | 2019-09-11 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | Carbocyclic sulfone RORγ regulator |
| WO2015129853A1 (en) * | 2014-02-27 | 2015-09-03 | 東レ株式会社 | Cyclic amine derivative and pharmaceutical use thereof |
-
2017
- 2017-01-25 TW TW106102788A patent/TWI691486B/en active
- 2017-01-27 SG SG11201805474PA patent/SG11201805474PA/en unknown
- 2017-01-27 US US16/072,482 patent/US10364222B2/en active Active
- 2017-01-27 ES ES17744386T patent/ES2822606T3/en active Active
- 2017-01-27 BR BR112018015125-4A patent/BR112018015125A2/en active Search and Examination
- 2017-01-27 DK DK17744386.8T patent/DK3409660T3/en active
- 2017-01-27 AU AU2017210685A patent/AU2017210685B2/en not_active Ceased
- 2017-01-27 EP EP17744386.8A patent/EP3409660B1/en active Active
- 2017-01-27 WO PCT/JP2017/002924 patent/WO2017131156A1/en active Application Filing
- 2017-01-27 CA CA3009971A patent/CA3009971C/en active Active
- 2017-01-27 KR KR1020187019685A patent/KR20180100573A/en active IP Right Grant
- 2017-01-27 JP JP2017507454A patent/JP6807054B2/en active Active
- 2017-01-27 MX MX2018008454A patent/MX2018008454A/en unknown
- 2017-01-27 CN CN201780008139.2A patent/CN108473426B/en active Active
- 2017-01-27 HU HUE17744386A patent/HUE050744T2/en unknown
- 2017-01-27 RU RU2018126968A patent/RU2696862C1/en active
- 2017-01-27 PL PL17744386T patent/PL3409660T3/en unknown
- 2017-01-27 MY MYPI2018000987A patent/MY195416A/en unknown
- 2017-01-27 PT PT177443868T patent/PT3409660T/en unknown
-
2018
- 2018-06-24 IL IL260230A patent/IL260230B/en active IP Right Grant
- 2018-06-27 ZA ZA2018/04325A patent/ZA201804325B/en unknown
- 2018-07-04 PH PH12018501434A patent/PH12018501434A1/en unknown
-
2019
- 2019-08-21 TR TR2019/12580U patent/TR201912580U5/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3409660B1 (en) | 2020-07-01 |
| PH12018501434A1 (en) | 2019-03-04 |
| WO2017131156A1 (en) | 2017-08-03 |
| HUE050744T2 (en) | 2021-01-28 |
| PT3409660T (en) | 2020-07-31 |
| EP3409660A4 (en) | 2019-06-26 |
| CA3009971C (en) | 2024-03-19 |
| MY195416A (en) | 2023-01-20 |
| MX2018008454A (en) | 2018-08-14 |
| EP3409660A1 (en) | 2018-12-05 |
| BR112018015125A2 (en) | 2019-02-26 |
| TWI691486B (en) | 2020-04-21 |
| AU2017210685A1 (en) | 2018-07-05 |
| US10364222B2 (en) | 2019-07-30 |
| DK3409660T3 (en) | 2020-08-31 |
| JPWO2017131156A1 (en) | 2018-11-22 |
| ES2822606T3 (en) | 2021-05-04 |
| PL3409660T3 (en) | 2021-01-25 |
| ZA201804325B (en) | 2019-09-25 |
| TW201731816A (en) | 2017-09-16 |
| IL260230A (en) | 2018-07-31 |
| AU2017210685B2 (en) | 2020-09-24 |
| RU2696862C1 (en) | 2019-08-07 |
| US20180370916A1 (en) | 2018-12-27 |
| JP6807054B2 (en) | 2021-01-06 |
| CN108473426A (en) | 2018-08-31 |
| CA3009971A1 (en) | 2017-08-03 |
| IL260230B (en) | 2020-06-30 |
| CN108473426B (en) | 2021-09-07 |
| TR201912580U5 (en) | 2020-09-21 |
| KR20180100573A (en) | 2018-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201705293B (en) | Cyclic amine derivative and pharmaceutical use thereof | |
| ZA201804325B (en) | Cyclic amine derivative and medical use thereof | |
| EP3402540C0 (en) | Sterilization device and methods | |
| SG10202010420TA (en) | Patient interface and aspects thereof | |
| HK1258409A1 (en) | Anti-cd22 antibody-maytansine conjugates and methods of use thereof | |
| ZA201801134B (en) | Hydroxytriazine compound and medical use thereof | |
| KR102276072B9 (en) | Cyclic amine derivative and pharmaceutical use thereof | |
| GB201709840D0 (en) | Methods and medical uses | |
| ZA201901263B (en) | Crystals of cyclic amine derivative and pharmaceutical use thereof | |
| HK1247220A1 (en) | Cyclic galanin-analogs and uses thereof | |
| EP3406620A4 (en) | Dicaffeoyl-spermidine cyclic derivative and use thereof | |
| HK1256605A1 (en) | Benzenesulfonyl-asymmetric ureas and medical uses thereof | |
| EP3275879A4 (en) | Cyclic amine derivative and use thereof for medical purposes | |
| IL275991A (en) | Cyclic amine derivative and medical use thereof | |
| EP3275878A4 (en) | Cyclic amine derivative and use thereof for medical purposes | |
| GB201709837D0 (en) | Methods and medical uses |